Literature DB >> 28820362

Characterization of patients with systemic lupus erythematosus who meet the diagnostic criteria for TAFRO syndrome.

E Hasegawa1, H Sato1,2, Y Wada1, K Takai3, A Wakamatsu1, Y Nozawa1, T Nakatsue1, T Kuroda2, Y Suzuki2, M Nakano4, I Narita2.   

Abstract

Purpose TAFRO syndrome is a novel disorder manifesting as fever, anasarca, thrombocytopenia, renal insufficiency and organomegaly, and its etiology has not been clarified. The aim of this study was to elucidate similarities and differences between systemic lupus erythematosus (SLE) and TAFRO syndrome. Methods We examined 46 consecutive patients diagnosed with SLE and determined whether they meet the proposed diagnostic criteria for TAFRO syndrome (2015 version). Results Of the 46 patients with SLE, four (8.7%) also met the TAFRO syndrome criteria (TAFRO-like group). All patients in the TAFRO-like group were males, and their mean age was significantly higher than that of the non-TAFRO group (67.5 ± 8.7 vs. 39.3 ± 18.1 years, p = 0.004). C-reactive protein and γ-glutamyl transpeptidase levels were significantly higher, and frequencies of anti-dsDNA and anti-Sm antibodies were significantly lower in the TAFRO-like than non-TAFRO group. Elder cases (onset age ≥ 50 years) met significantly more categories of the diagnostic criteria for TAFRO syndrome than did those with younger cases. Conclusions Several patients with SLE, especially elder cases, showed features similar to those of TAFRO syndrome. Although exclusion of SLE is needed in the diagnostic criteria for TAFRO syndrome, TAFRO syndrome-like SLE should be considered.

Entities:  

Keywords:  TAFRO syndrome; interleukin-6; systemic lupus erythematosus; vascular endothelial growth factor

Mesh:

Substances:

Year:  2017        PMID: 28820362     DOI: 10.1177/0961203317725589

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  3 in total

1.  Idiopathic multicentric Castleman disease with positive antiphospholipid antibody: atypical and undiagnosed autoimmune disease?

Authors:  Yoshito Nishimura; Asami Nishikori; Haruki Sawada; Torrey Czech; Yuki Otsuka; Midori Filiz Nishimura; Hiroki Mizuno; Naoki Sawa; Shuji Momose; Kumiko Ohsawa; Fumio Otsuka; Yasuharu Sato
Journal:  J Clin Exp Hematop       Date:  2022-03-05

2.  International definition of iMCD-TAFRO: future perspectives.

Authors:  Yoshito Nishimura; Midori Filiz Nishimura; Yasuharu Sato
Journal:  J Clin Exp Hematop       Date:  2022-04-27

3.  Severe refractory TAFRO syndrome requiring continuous renal replacement therapy complicated with Trichosporon asahii infection in the lungs and myocardial infarction: an autopsy case report and literature review.

Authors:  Arata Hibi; Ken Mizuguchi; Akiko Yoneyama; Takahisa Kasugai; Keisuke Kamiya; Keisuke Kamiya; Chiharu Ito; Satoru Kominato; Toshiyuki Miura; Katsushi Koyama
Journal:  Ren Replace Ther       Date:  2018-04-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.